UiPath Stock News

Is artificial intelligence a bubble? That's the trillion-dollar question.

NEW YORK--(BUSINESS WIRE)--UiPath announced UiPath Test Cloud, a new approach to software testing that uses AI to amplify tester productivity across the testing lifecycle.

In today's video, I discuss an artificial intelligence stock focused on agentic solutions, its business strategy, growth opportunities, potential risks, and whether investors should not ignore this AI stock.

UiPath's ARR is set to hit $1.816B in FY26 (+9% YoY), driven by 98% gross and 110% net retention. Cloud ARR surged past $975M (+50% YoY) as enterprise adoption of AI-driven automation accelerates. Profitability improved with a 32% non-GAAP margin, $328M free cash flow, and $1.7B cash (zero debt).

SYKESVILLE, Md.--(BUSINESS WIRE)--Coronis Health, (Coronis) a leading provider of healthcare revenue cycle management (RCM) solutions, is pleased to announce that it has leveraged the UiPath Platform™ to enhance its healthcare delivery systems. As part of its comprehensive digital transformation strategy, Coronis leverages the UiPath Platform to enhance advanced AI capabilities while ensuring t...

NEW YORK--(BUSINESS WIRE)--UiPath announced an Automation Cloud Public Sector free trial to help government agencies address operational challenges & productivity improvements.

UiPath (PATH) reported quarterly financial results that disappointed stock market investors.

Enterprise automation and artificial intelligence (AI) software company UiPath has acquired AI platform Peak. “With the acquisition of Peak, we are accelerating our mission to strengthen our vertical AI solutions strategy,” Daniel Dines, UiPath's founder and chief executive, said in a news release Thursday (March 13).